News |
Events |
meriT–1 study completes 2 years of follow up
• In this first in man study, BioMime was deployed in single de novo lesions and ![]() meriT-2 study on BioMime SES completes recruitment
• MeriT-2 was a multi-centric study conducted in India involving complex real world patients. ![]() BIOMIME Sirolimus Eluting Coronary Stent System Receives Regulatory Approvals
• Receives Indian Approval – DCG(I)January 2009 ![]() BIOMIME Sirolimus Eluting Coronary Stent System Is Commercially Available In
• India ![]() Meril Announces Direct Operations
In order to attend and service large markets, Meril has set up its own direct operations in Germany for Europe and Brazil for Latin America. |
|